Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.
第一作者:
Melissa A,Daubert
第一单位:
From the Duke University Medical Center, Duke Clinical Research Institute, Durham, NC (M.A.D., E.Y., G.D., H.B., P.S.D.); Medical University of Pleven, Bulgaria (S.M.); Inova Heart and Vascular Institute, Falls Church, VA (C.O.); Henry Ford Hospital, Detroit, MI (S.G., H.N.S.); and Tufts Medical Center, Boston, MA (J.E.U.). melissa.daubert@duke.edu.
作者:
主题词
老年人(Aged);保加利亚(Bulgaria);心血管药物(Cardiovascular Agents);双盲法(Double-Blind Method);超声心动描记术(Echocardiography);能量代谢(Energy Metabolism);女(雌)性(Female);心力衰竭(Heart Failure);人类(Humans);输注, 静脉内(Infusions, Intravenous);男(雄)性(Male);中年人(Middle Aged);线粒体, 心脏(Mitochondria, Heart);寡肽类(Oligopeptides);前瞻性研究(Prospective Studies);每搏输出量(Stroke Volume);治疗结果(Treatment Outcome);心室功能, 左(Ventricular Function, Left)
DOI
10.1161/CIRCHEARTFAILURE.117.004389
PMID
29217757
发布时间
2018-02-07
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文